Your browser doesn't support javascript.
loading
Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts.
Karavasiloglou, Nena; Hughes, David J; Murphy, Neil; Schomburg, Lutz; Sun, Qian; Seher, Vartiter; Rohrmann, Sabine; Weiderpass, Elisabete; Tjønneland, Anne; Olsen, Anja; Overvad, Kim; Boutron-Ruault, Marie-Christine; Mancini, Francesca Romana; Mahamat-Saleh, Yahya; Kaaks, Rudolf; Kuhn, Tilman; Schulze, Matthias B; Tumino, Rosario; Panico, Salvatore; Masala, Giovanna; Pala, Valeria; Sacerdote, Carlotta; Derksen, Jeroen W G; Skeie, Guri; Hjartåker, Anette; Lasheras, Cristina; Agudo, Antonio; Sánchez, Maria-José; Chirlaque, Maria-Dolores; Ardanaz, Eva; Amiano, Pilar; Van Guelpen, Bethany; Gylling, Björn; Bradbury, Kathryn E; Papier, Keren; Freisling, Heinz; Aglago, Elom K; Cross, Amanda J; Riboli, Elio; Aune, Dagfinn; Gunter, Marc J; Jenab, Mazda.
Afiliación
  • Karavasiloglou N; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Hughes DJ; Cancer Biology and Therapeutics Group, UCD Conway Institute, School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
  • Murphy N; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Schomburg L; Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Sun Q; Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Seher V; Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Rohrmann S; Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Weiderpass E; Office of the Director, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Tjønneland A; Danish Cancer Society Research Center, Diet, Genes and Environment, Copenhagen, Denmark; University of Copenhagen, Department of Public Health, Copenhagen, Denmark.
  • Olsen A; Danish Cancer Society Research Center, Diet, Genes and Environment, Copenhagen, Denmark; University of Århus, Department of Public Health, Århus, Denmark.
  • Overvad K; University of Århus, Department of Public Health, Århus, Denmark.
  • Boutron-Ruault MC; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France; Gustave Roussy, Villejuif, France.
  • Mancini FR; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France; Gustave Roussy, Villejuif, France.
  • Mahamat-Saleh Y; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France; Gustave Roussy, Villejuif, France.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kuhn T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; School of Biological Sciences, Queens University of Belfast, Belfast, Northern Ireland.
  • Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
  • Tumino R; Hyblean Association for Epidemiology Research, AIRE-ONLUS Ragusa, Italy.
  • Panico S; Dipartimento Di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • Masala G; Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Pala V; Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.
  • Derksen JWG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Skeie G; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Norway.
  • Hjartåker A; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Norway.
  • Lasheras C; Department of Functional Biology, Faculty of Medicine, University of Oviedo, Asturias, Spain.
  • Agudo A; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Sánchez MJ; Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Chirlaque MD; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Spain.
  • Ardanaz E; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Navarra Public Health Institute, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Amiano P; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa; Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastián, Spain.
  • Van Guelpen B; Department of Radiation Sciences, Oncology Umeå University, Umeå, Sweden; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
  • Gylling B; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  • Bradbury KE; National Institute for Health Innovation, The University of Auckland, New Zealand.
  • Papier K; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Freisling H; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Aglago EK; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Cross AJ; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Riboli E; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Aune D; Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
  • Gunter MJ; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
  • Jenab M; Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Electronic address: jenabm@iarc.fr.
Am J Clin Nutr ; 117(1): 33-45, 2023 01.
Article en En | MEDLINE | ID: mdl-36789942
ABSTRACT

BACKGROUND:

Higher dietary calcium consumption is associated with lower colorectal cancer (CRC) risk. However, little data are available on the association between circulating calcium concentrations and CRC risk.

OBJECTIVES:

To explore the association between circulating calcium concentrations and CRC risk using data from 2 large European prospective cohort studies.

METHODS:

Conditional logistic regression models were used to calculate multivariable-adjusted ORs and 95% CIs in case-control studies nested within the European Prospective Investigation into Cancer and Nutrition (EPIC; n-cases = 947, n-controls = 947) and the UK Biobank (UK-BB; n-cases = 2759, n-controls = 12,021) cohorts.

RESULTS:

In EPIC, nonalbumin-adjusted total serum calcium (a proxy of free calcium) was not associated with CRC (OR 0.94; 95% CI 0.85, 1.03; modeled as continuous variable, per 1 mg/dL increase), colon cancer (OR 0.93; 95% CI 0.82, 1.05) or rectal cancer (OR 1.01; 95% CI 0.84, 1.20) risk in the multivariable adjusted model. In the UK-BB, serum ionized calcium (free calcium, most active form) was inversely associated with the risk of CRC (OR 0.85; 95% CI 0.76, 0.95; per 1 mg/dL) and colon cancer (OR 0.78; 95% CI 0.68, 0.90), but not rectal cancer (OR 1.02; 95% CI 0.83, 1.24) in multivariable adjusted models. Meta-analysis of EPIC and UK-BB CRC risk estimates showed an inverse risk association for CRC in the multivariable adjusted model (OR 0.90; 95%CI 0.84, 0.97). In analyses by quintiles, in both cohorts, higher levels of serum calcium were associated with reduced CRC risk (EPIC ORQ5vs.Q1 0.69; 95% CI 0.47, 1.00; P-trend = 0.03; UK-BB ORQ5vs.Q1 0.82; 95% CI 0.72, 0.94; P-trend < 0.01). Analyses by anatomical subsite showed an inverse cancer risk association in the colon (EPIC ORQ5vs.Q1 0.63, 95% CI 0.39, 1.02; P-trend = 0.05; UK-BB ORQ5vs.Q1 0.75; 95% CI 0.64, 0.88; P-trend < 0.01) but not the rectum.

CONCLUSIONS:

In UK-BB, higher serum ionized calcium levels were inversely associated with CRC, but the risk was restricted to the colon. Total serum calcium showed a null association in EPIC. Additional prospective studies in other populations are needed to better investigate these associations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Am J Clin Nutr Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Am J Clin Nutr Año: 2023 Tipo del documento: Article País de afiliación: Suiza